Insempra Appoints Two New Members to its Scientific Advisory Board

Written by: Editor
Published on: 27 Oct 2022

InsempraMunich/London, 26 October 2022 - Insempra, a biology-powered company enabling businesses to make superior products in partnership with nature, today announces the appointment of Professor Michael Jewett, PhD and Professor Paul Freemont to its scientific advisory board (SAB). The SAB is comprised of world-renowned academics to provide scientific review and high-level counsel on the Company’s R&D to advance its development of intrinsically sustainable ingredients at scale. 

The SAB works closely with Insempra’s leadership team as the Company advances its nutrition, beauty and fibers platforms to accelerate the discovery, design and development of multi-functional superior ingredients for wide-scale market application.

Jens Klein, CEO of Insempra, commented: "We are honored to have these accomplished scientific leaders join Insempra's Scientific Advisory Board. These individuals have made significant contributions and pioneered breakthroughs in biological engineering and, together, they bring a wealth of knowledge and experience to Insempra, as we work to develop our superior ingredient product platforms. We look forward to harnessing the knowledge and experience of these outstanding individuals as we advance our platform technology in precision fermentation and cell-free bioengineering and our ongoing research and development efforts in a number of large-scale market applications."

Further details on the new SAB members

Professor Michael Jewett, PhD is a Professor of Chemical and Biological Engineering, and Director of the Center for Synthetic Biology at Northwestern University. Dr. Jewett’s lab focuses on advancing synthetic biology research in support of planet and societal health. He is the recipient of the NIH Pathway to Independence Award, David and Lucile Packard Fellowship in Science and Engineering, Camille-Dreyfus Teacher-Scholar Award, and a Finalist for the Blavatnik National Awards for Young Scientists, among others. He is the co-founder of SwiftScale Biologics, Stemloop, Inc., Pearl Bio, and Design Pharmaceuticals. Dr. Jewett is a Fellow of AIMBE, AAAS, and NAI.

Professor Paul Freemont is Co-founder of the Imperial College Centre for Synthetic Biology (2009) and Co-founder/Co-director of the National UK Innovation and Knowledge Centre for Synthetic Biology (SynbiCITE; since Oct 2013) at Imperial College London. The Centre aims to enable synthetic biology research in application areas like biosensors, biosynthesis, bioprocessing and metabolic and genome engineering and enable the translation of new synthetic biology technologies into start-ups, SMEs and industry. Professor Freemont’s research interests are focused on developing synthetic biology foundational tools, automation and biofoundries for specific applications including biosensing and metabolic engineering. He is author of over 300 scientific publications and is an elected member of the European Molecular Biology Organisation and also a Fellow of the Royal Societies of Biology, Chemistry and Medicine and is an Honorary Fellow of the Royal College of Art.